Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000909325) titled 'A Phase 1, Open-label, Single-arm Basket Trial of Intravenously Administered Psilocin (TRP-8803) in Anorexia Nervosa, Fibromyalgia, Generalised Anxiety Disorder, Irritable Bowel Syndrome, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, and Treatment-resistant Major Depressive Disorder' on July 23.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety
Primary Sponsor: Tryptamine Therapeutics
Condition:
Anorexia Nervosa
Fibromyalgia
Generalized Anxiety Disorder
Irritable Bo...